Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs

Sep.10
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.

Key Points

  • USSTC broke ground on the roughly $250 million Hopkinsville project on September 8.
  • The new facility will cover about 270,000 square feet and is expected to add more than 200 jobs.
  • The project will consolidate some processing, manufacturing and packaging operations currently spread between Hopkinsville and Nashville.
  • Production at the Nashville facility is expected to wind down by early 2028 as Altria modernizes its manufacturing footprint.

2Firsts

September 10, 2026

According to The Lane Report and local media on September 8, U.S. Smokeless Tobacco Company, an Altria Group operating company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky.

The project will add roughly 270,000 square feet at USSTC’s existing Hopkinsville site, create more than 200 jobs and absorb parts of the processing, manufacturing and packaging work currently handled in Nashville, Tennessee.

USSTC Is a Core Altria Smokeless Tobacco Business

USSTC is one of Altria’s operating companies and produces moist smokeless tobacco brands including Copenhagen, Skoal, Red Seal and Husky.

Altria acquired USSTC in 2009 and incorporated the business into its U.S. tobacco operations.

The Hopkinsville investment is therefore part of a broader Altria manufacturing strategy rather than a standalone expansion by an independent company.

USSTC already operates tobacco-processing activities in Hopkinsville. The new facility will expand the site and consolidate operations now divided between Hopkinsville and Nashville.

$250 Million Project to Add More Than 200 Jobs

The total investment is expected to be about $250 million.

The new facility will span approximately 270,000 square feet and is expected to create more than 200 jobs.

Kentucky officials have previously said the project could roughly double USSTC’s workforce in the state once fully implemented.

Kentucky Governor Andy Beshear also attended events surrounding the project and highlighted the investment as part of the state’s manufacturing and employment growth.

Hopkinsville to Absorb Nashville Production

USSTC announced in May 2026 that it planned to gradually transfer manufacturing operations from its Nashville facility to Hopkinsville.

The Nashville plant covers roughly 800,000 square feet and employs more than 300 people. It handles portions of post-processing and packaging for brands including Copenhagen, Skoal, Red Seal and Husky.

Under the company’s plan, production in Nashville is expected to wind down by early 2028.

Operations will be consolidated in Hopkinsville, while the Nashville property is expected to be sold after production ends.

The Hopkinsville project therefore represents not simply new capacity, but a restructuring of Altria’s U.S. smokeless tobacco manufacturing network.

Altria Says Move Will Improve Efficiency and Resilience

Altria has said concentrating operations in Hopkinsville is expected to reduce fixed costs, improve efficiency and strengthen manufacturing resilience.

The project will bring processing, production and packaging operations that were previously spread across multiple locations into a more consolidated footprint.

For the traditional smokeless tobacco business, that can reduce cross-site complexity and duplicated infrastructure.

The investment also shows that while Altria continues to expand into nicotine pouches, vaping and other smoke-free categories, it is still committing significant capital to modernize its established moist smokeless tobacco operations.

Distinct From Altria’s Other Smoke-Free Platforms

Altria’s smoke-free portfolio extends beyond USSTC.

The group also operates the on! and on! PLUS nicotine pouch business through Helix Innovations, owns NJOY in vaping, and is pursuing heated tobacco-related opportunities.

The Hopkinsville project, however, relates specifically to USSTC’s traditional smokeless tobacco manufacturing operations, not nicotine pouch or vaping production.

That distinction matters.

In U.S. regulatory and corporate usage, “smokeless tobacco” includes traditional tobacco-containing products such as moist smokeless tobacco and should not automatically be treated as synonymous with newer tobacco-free oral nicotine products.

Manufacturing Consolidation Is the Core of the Project

From Altria’s broader manufacturing perspective, the central purpose of the Hopkinsville expansion is the consolidation of USSTC’s existing production footprint rather than the launch of a new product category.

As Nashville production is phased out, Hopkinsville is set to become a more important manufacturing hub within USSTC’s network.

For Altria, the project brings together capacity reallocation, fixed-cost reduction and long-term infrastructure investment in its traditional smokeless tobacco business.

The expansion is expected to progress over the next two years, in line with the company’s plan to wind down Nashville production by early 2028.

Follow 2Firsts for timely updates on global tobacco and nicotine industry developments, corporate strategy and market trends.

Cover Image: christiancountynow


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
South Korea Vape Strategies Diverge as BAT Reconsiders Exit and PMI Takes VEEV to About 14,000 Stores
BAT Rothmans says it previously considered exiting South Korea's vaping market because of competitive pressure from unregulated products, but is now reassessing conditions following changes to the country's nicotine regulatory framework. Vuse and other BAT vaping products remain available through existing distribution channels. The statement followed a South Korean media report that interpreted BAT's broader withdrawal from selected Vapour markets as a full exit from South Korea. Meanwhile, Philip Morris International launched VEEV inPRIME in the country in June and began expanding distribution to around 14,000 convenience stores and other retail channels in July. The contrasting moves highlight differing investment strategies as South Korea's regulated vaping market evolves.
Aug.14
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07